
“The spirit of this collaboration is to combine Sanovas’ and Mayo Clinic’s respective technologies and expertise to advance precision in the treatment and control of asthma for patients with severe persistent asthma. We expect to commercialize an intelligent set of next generation tools that will afford clinicians an intuitive command of the operating environment. We welcome Mayo Clinic’s participation in both the inception of certain aspects of the technology and their ongoing participation in the development, clinical investigation and study of the technology.”
— Larry Gerrans, CEO of Sanovas